Bicycle Therapeutics (BCYC) EBIT Margin (QoQ) (2018 - 2026)
Bicycle Therapeutics (BCYC) EBIT Margin (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Bicycle Therapeutics | 289.88 Mn | 289.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -733,089.00 |
| Dec 31, 2025 | 50,712.00 |
| Sep 30, 2025 | 240,718.00 |
| Jun 30, 2025 | -226,216.00 |
| Mar 31, 2025 | 112,113.00 |
| Dec 31, 2024 | 56,109.00 |
| Sep 30, 2024 | -188,756.00 |
| Jun 30, 2024 | -19,335.00 |
| Mar 31, 2024 | 71,239.00 |
| Dec 31, 2023 | -6,823.00 |
| Sep 30, 2023 | -57,086.00 |
| Jun 30, 2023 | 47,555.00 |
| Mar 31, 2023 | -47,036.00 |
| Dec 31, 2022 | 59,545.00 |
| Sep 30, 2022 | -46,382.00 |
| Jun 30, 2022 | 19,431.00 |
| Mar 31, 2022 | 41,710.00 |
| Dec 31, 2021 | -79,661.00 |
| Sep 30, 2021 | 63,801.00 |
| Jun 30, 2021 | -8,162.00 |